Share on StockTwits

Abcam Plc (LON:ABC) was downgraded by equities researchers at Canaccord Genuity to a “hold” rating in a research report issued on Thursday. They currently have a GBX 425 ($7.05) price target on the stock, up from their previous price target of GBX 400 ($6.64). Canaccord Genuity’s price objective would indicate a potential downside of 0.08% from the stock’s previous close.

Shares of Abcam Plc (LON:ABC) traded down 2.81% during mid-day trading on Thursday, hitting GBX 412.5594. The stock had a trading volume of 428,161 shares. Abcam Plc has a 52 week low of GBX 270.88 and a 52 week high of GBX 533.50. The stock has a 50-day moving average of GBX 402.7 and a 200-day moving average of GBX 399.8.

A number of other analysts have also recently weighed in on ABC. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Abcam Plc in a research note on Friday, August 1st. They now have a GBX 490 ($8.13) price target on the stock. Finally, analysts at FinnCap reiterated a “hold” rating on shares of Abcam Plc in a research note on Tuesday, July 22nd. They now have a GBX 390 ($6.47) price target on the stock. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of GBX 420.50 ($6.98).

Abcam plc is a producer and distributor of research-grade antibodies and associated protein research products, which are essential tools for life scientists, enabling them to analyse components of living cells at the molecular level.

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.